BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29707153)

  • 1. Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
    Tailor PD; Kodeboyina SK; Bai S; Patel N; Sharma S; Ratnani A; Copland JA; She JX; Sharma A
    Oncotarget; 2018 Apr; 9(25):17876-17888. PubMed ID: 29707153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation.
    Ni T; Zhao RH; Wu JF; Li CY; Xue G; Lin X
    Biochem Genet; 2024 Feb; ():. PubMed ID: 38316654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
    Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
    Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
    Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
    Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.
    Planque C; Choi YH; Guyetant S; Heuzé-Vourc'h N; Briollais L; Courty Y
    Clin Chem; 2010 Jun; 56(6):987-97. PubMed ID: 20360129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families.
    Elliott MB; Irwin DM; Diamandis EP
    Genomics; 2006 Nov; 88(5):591-9. PubMed ID: 16829021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil.
    Lizama AJ; Andrade Y; Colivoro P; Sarmiento J; Matus CE; Gonzalez CB; Bhoola KD; Ehrenfeld P; Figueroa CD
    Innate Immun; 2015 Aug; 21(6):575-86. PubMed ID: 25563717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
    Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
    Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
    Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP
    Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
    Komatsu N; Saijoh K; Kuk C; Shirasaki F; Takehara K; Diamandis EP
    Br J Dermatol; 2007 May; 156(5):875-83. PubMed ID: 17459012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.
    Dong Y; Matigian N; Harvey TJ; Samaratunga H; Hooper JD; Clements JA
    Biol Chem; 2008 Feb; 389(2):99-109. PubMed ID: 18163887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.
    Komatsu N; Takata M; Otsuki N; Toyama T; Ohka R; Takehara K; Saijoh K
    J Invest Dermatol; 2003 Sep; 121(3):542-9. PubMed ID: 12925213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel overexpression of seven kallikrein genes in ovarian cancer.
    Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression of Kallikreins in Breast Cancer Cell Lines.
    Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R
    Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
    Clements J; Hooper J; Dong Y; Harvey T
    Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
    Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
    Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of multiple kallikreins in high-grade astrocytoma.
    Drucker KL; Gianinni C; Decker PA; Diamandis EP; Scarisbrick IA
    BMC Cancer; 2015 Aug; 15():565. PubMed ID: 26231762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.